Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Dev Comp Immunol. Author manuscript; available in PMC 2010 April 9.
Published in final edited form as:
PMCID: PMC2852107

Nitric oxide production and nitric oxide synthase type 2 expression by cotton rat (Sigmodon hispidus) macrophages reflect the same pattern as human macrophages


Our knowledge of the antibacterial role of nitric oxide (NO) during infection is based on studies of murine macrophages, which secrete large amounts of NO. In contrast, human macrophages produce very little NO and its relevance as an antibacterial mediator during infection of humans is uncertain. We have defined bone marrow-derived macrophages from cotton rats (Sigmodon hispidus). These macrophages display phenotypical and functional characteristics similar to other rodent and human macrophages. The most interesting finding was the low level of NO production which is in contrast to findings for murine macrophages, but consistent with those of humans. In spite of these low levels, inhibition of NO production led to a decrease in killing of bacteria. Cotton rats are highly susceptible to a variety of human pathogens and therefore offer a rodent model of infectious diseases with similar characteristics to humans in terms of NO production.

Keywords: Susceptibility to infection, Macrophages, Superoxide, Nitric oxide, Immune system, Cotton rat

1. Introduction

Macrophages play a very important role in antimicrobial immunity by linking the innate and adaptive immune responses. As part of the innate immune response, macrophages are able to phagocytose and kill pathogens; as part of the adaptive immune response, they can stimulate antigen-specific immune responses through antigen presentation and secretion of cytokines. For this reason, a variety of pathogens have devised strategies to subvert macrophage functions (for review [1]). Through the study of mouse and rat macrophages it was determined that nitric oxide (NO) is a major antimicrobial molecule and produced in large quantities [2]. NO secretion is generated by nitric oxide synthase type 2 (NOS 2) which in turn is stimulated by a variety of pro-inflammatory signals like tumor necrosis factor, interferon gamma (IFNγ), and infection with a variety of pathogens. When investigators attempted to apply these findings from rodent macrophages to human mononuclear phagocytes they had difficulties demonstrating NOS2 expression and NO production (for review [3]). With improvements in techniques and reagents, recent studies have shown low levels of NOS2 expression and NO production in human macrophages ([4,5]). It is currently thought that NO expression in human macrophages is mainly involved in signal transduction rather than antimicrobial activity [3], although antimicrobial activity of NO produced by human macrophages has been established [5]. Whether this difference between human and rodent macrophages is important in the pathogenesis of infectious diseases and therefore constitutes an important aspect in which murine models differ from humans has not been established.

Cotton rats (Sigmodon hispidus) are a very useful animal model for infectious disease research due to their susceptibility to a variety of human pathogens (for review [6]). As a model for viral diseases, cotton rats have been used for either acute respiratory infection with measles virus [7,8], respiratory syncytial virus [9,10], metapneumovirus [1113], parainfluenza virus [14] and influenza A virus [15,16] or chronic infection with human immunodeficiency virus [17,18], herpes simplex virus type 1 [19] and 2 [20] and adenovirus [21]. As a model for bacterial diseases cotton rats have been infected with Helicobacter pylori [22], Staphyloccocus aureus [23], Mycobacterium tuberculosis [24], Borrelia burgdorferi [25,26] and Francisella tularensis [27]. The use of cotton rats as a model of infectious diseases has increased over the last decade, mainly due to commercially available inbred animals and the development of methods and reagents for the analysis of the immune system [6,28]. In this study, we have defined the phenotypical and functional characteristics of bone marrow-derived macrophages from cotton rats. This allows for the analysis of macrophage–pathogen interaction during infection of cotton rats with human pathogens. In contrast to other rodent and similar to human macrophages, cotton rat macrophages demonstrate low levels of NOS2 expression and NO production. The similarities between human and cotton rat macrophages might help to explain the high susceptibility of this rodent to human pathogens.

2. Materials and methods

2.1. Animals

Inbred cotton rats and C3H mice were obtained from Harlan, Indianapolis. Female animals from 6 to 10 weeks of age were used. The animals were bought specific pathogen free according to the breeder’s specification and were maintained in a barrier system. Animals were kept under controlled environmental conditions of 22 ± 1 °C and a 12-h light cycle. All animals were euthanized by CO2 inhalation.

2.2. Bone marrow-derived macrophages

Bone marrow was aspirated aseptically from the femoral diaphyseal marrow cavity of female cotton rats and cells were isolated after centrifugation. Bone marrow cells were then cultured in 10 cm perfluoroalkoxy polymer resin dishes for 7 days in the presence of 100 ng/ml recombinant mouse M-CSF (R&D Systems) in RPMI 1640 supplemented with 10% FCS, 1% non-essential amino acids, 1% sodium pyruvate, 2 mmol/L glutamine, 50 IU penicillin, 50 mg streptomycin/L and 5 × 10−5 M β-mercaptoethanol. After 7 days in culture plastic adherence of cells is characteristic of macrophage differentiation. Macrophages were primed in RPMI/10 (RPMI 1640 with 10% FCS, 1% non-essential amino acids, 1% sodium pyruvate, 2 mmol/L glutamine, 50 IU penicillin, 50 mg streptomycin/L, 5 × 10−5 M β-mercaptoethanol) supplemented with 20% tissue culture supernatant from Concanavalin A stimulated spleen cells (containing IFNγ). To produce this supernatant, 5–10 × 107 cotton rat splenocytes were cultured in RPMI/10 containing 2.5 µg/mL Concanavalin A at 37 °C. After 36 h, 10 mg/mL methyl-α-mannopyranoside was added and supernatant obtained by centrifugation. The supernatant was filtered prior to use.

2.3. Non-specific esterase staining

Macrophages were stained for cytoplasmic non-specific esterase activity using α-naphthyl acetate (non-specific esterase) (Sigma) according to the manufacturer’s instructions.

2.4. Cloning of cotton rat CD14 and production of antiserum

Isolation of the CD14 gene was performed by screening cDNA libraries constructed from LPS-stimulated cotton rat macrophages using standard recombinant DNA techniques. cDNA libraries were constructed using the SuperScriptTM Plasmid System for cDNA synthesis and plasmid cloning (Invitrogen) and transformed into DH5a maximum efficiency Escherichia coli (Invitrogen). To clone cotton rat CD14, sense and anti-sense degenerate primers based on the sequence homology of CD14 for various species (mouse, rat, rabbit and human) were synthesized. With these primers (see Table 1) a probe of 938 bp was amplified from cotton rat macrophage cDNA and used for screening of a cotton rat macrophage library. The full-length cotton rat CD14 gene was cloned into pcDNA-3. This plasmid was used to stably transfect L929 cells using lipofectin, and gentamycin was used as the selection agent. C3H mice were inoculated with 107 CD14-transfected L929 cells in weekly intervals for 3 weeks intraperitoneally. Three weeks later mice were euthanized and serum was obtained by cardiac puncture.

Table 1
Sequences of primers used for the study of cotton rat macrophages.

2.5. Flow cytometry

Spleen cells or macrophages were incubated with primary antibodies MHC I [29] (clone W6/32), MHC II [30] (clone 13/4) cotton rat-CD4 [31] or a mouse serum specific for cotton rat CD14. The secondary donkey anti-mouse serum labeled with FITC was pre-absorbed with cotton rat serum. Subsequently cells were analyzed by flow cytometry (Facscan, Becton Dickenson).

2.6. Reverse transcriptase polymerase chain reaction

Macrophages were primed with 20% supernatant from Concanavalin A stimulated spleen cells and stimulated further with 100 ng/mL LPS (E. coli 0127:B8; Sigma). RNA was isolated using the Qiagen RNeasy kit (Ambion). RNA concentration was calculated using 260/280 nm light absorbance (ND-1000 Spectrophotometer, Nano Drop Technologies). To ensure RNA sample integrity, each sample was probed for the housekeeping gene β actin. All reactions were also performed without reverse transcriptase to verify the absence of genomic DNA contamination. Standard RT-PCR was performed using M-MLV reverse transcriptase (Invitrogen). NOS2 was amplified by standard RT-PCR (Table 1 for primer sequences). Samples were analyzed by 2.0% agarose gel electrophoresis and stained with ethidium bromide.

Real time RT-PCR was performed using the LightCycler RNA Amplification Kit SYBR Green I (Roche) for IL12p35, IL18, TGFβ, TNFα and β actin (Table 1 for primer sequences). Total SYBR Green fluorescence was measured at conditions that preserve specific gene product amplicons but not non-specific amplification products. Data were analyzed using LightCycler Software Version 3. Quantification was based upon fit points analysis with arithmetic baseline adjustment. Melting peak and melting curve analyses were performed using the polynomial calculation method. RT-PCR standards were generated by in vitro transcription. Template for these transcription reactions was an expression plasmid containing the complete mRNA sequence. Plasmid was linearized to introduce a consistent transcription stop site. The transcripts were treated with DNase (Ambion) to remove the template plasmid. Nucaway columns (Ambion) were used to remove free nucleotides. RNA transcripts were quantified by optical density. Serial dilutions of the RNA transcripts were made for use as standards for the real time RT-PCR; samples were also analyzed by agarose gel electrophoresis (2.0%) and stained with ethidium bromide.

2.7. Bacterial killing

Bone marrow-derived macrophages (5 × 105/well) were plated in 24-well plates, primed for 48 h with 0.5 µg/ml recombinant cotton rat IFNγ and infected with E. coli.. The cells were washed to remove extracellular bacteria. Cell lysates were harvested at times zero and 120 min post infection. Serial dilutions of the homogenates were plated in duplicate on LB agar plates to determine the number of viable intracellular bacteria. After incubation overnight at 37 °C, colonies were counted. In some experiments 1400 W (Sigma), an inhibitor of NOS2, was added to the macrophage media for 30 min prior to and during the 15 min incubation with E. coli.

2.8. Nitric oxide detection by Griess reaction

Cotton rat bone marrow-derived macrophages were plated in 96-well plates in triplicates and primed with RPMI containing 20% supernatant of Concanavalin A stimulated spleen cells (containing IFNγ). Macrophages were triggered with 100 ng/mL LPS (E. coli O127:B8, Sigma), infection with Listeria monocytogenes (EGD-Psod-gfp; MOI of 10), PMA 100 ng/ml or TNF-α 10 pg/mL (R&D Systems). At 24, 36 and 48 h, 50 µL of culture supernatant was collected and transferred to a 96-well plate. Serial dilutions of a 2mM stock of NaNO2 solution were used to generate a standard (1.25 µM through 100 µM). 50 µL of 0.1% (w/v) N-(1-naphthyl) ethylenediamine dihydrochloride (in 2.5% phosphoric acid) and 50 µL of 1% (w/v) sulfanilamide (in 2.5%phosphoric acid) were added to each well. The absorbance was measured at 550 nm in a microwell plate reader.

2.9. Nitric oxide detection by electron paramagnetic resonance (EPR) spectroscopy

The nitric oxide generated by macrophages was measured using Fe-MGD complex (1mM Fe2+, 5 mM N-methyl-d-glucaminedithio-carbamate (MGD) in PBS, pH 7.4). Stimulated bone marrow-derived macrophages were incubated with Fe-MGD for 30 min, and then EPR spectra were recorded in a quartz flat cell at room temperature with a Bruker ER 300 spectrometer operating at X-band with 100 kHz modulation frequency and a TM110 cavity as described [33,34]. S-Nitroso-N-acetyl-penicillamine (SNAP, 10 µM) was used as NO standard. NO scavenger, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO, Sigma) (50 µM) was used to verify the specificity of the EPR signal.

2.10. Nitric oxide detection by DAF fluorescence

The intracellular NO production was determined using diaminofluoresceine-2 diacetate (DAF-2A) fluorescence. Macrophages grown on glass cover slips were preloaded with DAF-2A (10 µM) for 30 min, washed to remove excess fluorophore and then stimulated with 100 ng/mL LPS for 6 h. SNAP (100 µM) was used as a positive control which releases nitric oxide under physiological conditions. NO scavenger, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO, Sigma) (50 µM) was used to verify the specificity of the DAF fluorescence. Macrophages were rinsed with PBS and examined using a Leica TCS SP2 AOBS Confocal Laser Scanning Microscope under a magnification of 40× at 490 and 520 nm. The fluorescence intensity was quantitatively determined using Leica Confocal Software Lite.

2.11. Superoxide and hydrogen peroxide detection

Bone marrow-derived macrophages were plated in a black, clear-bottomed 96-well plate (106 cells/well) in replicates of six. Macrophages were primed with 10 U/mL recombinant cotton rat IFNγ (R&D Systems) for 48 h and then washed with Hank’s balanced salt solution (HBSS). Subsequently, lucigenin (10 µM) or luminol (100 mM) was added to the each well and macrophages were stimulated with PMA (100 ng/mL) or Zymosan A (100 µg). Luminescence measurements were taken immediately (PMA) or after centrifugation (Zymosan A) and then for every 5 min in the Microbeta Scintillation Counter (Perkin–Elmer). Cells were maintained at 37 °C between the readings.

3. Results

3.1. Culture conditions for the generation of cotton macrophages from bone marrow

In order to determine the antimicrobial activity of cotton rat macrophages, we established a method to culture a homogenous cell population from bone marrow and defined these cells as macrophages by phenotypical and functional criteria. These macrophages were used for phagocytosis assays and tested for their secretion of reactive oxygen and nitrogen intermediates. Based on protocols for the generation of mouse macrophages from bone marrow, we plated 5 × 106 bone marrow cells in a 10 cm Petri dish in RPMI medium supplemented with 10% FCS and 5 × 10−5 M β-mercaptoethanol. As a growth promoter L929 supernatant (which contains mouse M-CSF), recombinant mouse or human M-CSF was added. The best growth of cells from bone marrow was observed after the addition of recombinant mouse M-CSF that yielded 7.5 × 106 to 1 × 107 macrophages per plate (twice as much as after addition of human M-CSF). After the addition of L929 supernatant, cells grew poorly. The cells growing after 7 days in culture had a homogenous phenotype of large cells adherent to plastic and contained granules expressing non-specific esterase, an enzyme typically expressed by macrophages (data not shown).

3.2. Expression of cell surface markers on cotton rat macrophages

In order to define cotton rat macrophages, further, they were stained with antibodies against MHC class I (clone W6/32; [29]), MHC class II (clone 13/4; [30]), CD14 and CD4 (clone CR-CD4; [31]). W6/32 is an antibody specific for human MHC I and is cross-reactive with cotton rat MHC I by immunoprecipitation (data not shown). It demonstrates a typical pattern of MHC I expression by flow cytometry on spleen cells and macrophages obtained by peritoneal lavage (Fig. 1). 13/4 is an antibody specific for mouse MHC II; it did not immunoprecipitate cotton rat MHC II (data not shown). However, it inhibited the proliferation of measles virus specific CD4 T cells in tissue culture [31], and demonstrated a typical pattern of expression by flow cytometry on spleen cells and macrophages obtained by peritoneal lavage (Fig. 1). Staining with these two antibodies revealed that bone marrow-derived macrophages of cotton rats express MHC I, but little MHC II. In order to increase MHC II expression, macrophages were treated with recombinant IFNγ for 48 h, and this treatment increased MHC II expression (Fig. 1). For staining against CD14, L929 cells stably transfected with cotton rat CD14 were used to produce a mouse polyclonal antiserum specific for cotton rat CD14. All cells derived by culture from bone marrow expressed CD14 (Fig. 1). It has been shown that rat and human macrophages express CD4 but staining with CR-CD4 (a monoclonal antibody specific for cotton rat CD4 [31] demonstrated no CD4 expression on cotton rat macrophages (data not shown).

Fig. 1
Expression of MHC I, MHC II and CD14 by cotton rat macrophages. Expression of MHCI, MHCII and CD14 on spleen cells, peritoneal macrophages and bone marrow-derived macrophages. MHC class II expression increased with stimulation of the bone marrow-derived ...

3.3. Cytokine expression of bone marrow-derived macrophages

Macrophages typically express TNFα, TGFβ, IL12 and IL18. The expression of these cytokines by bone marrow-derived cotton rat macrophages was determined by real time RT-PCR. TNFα, TGFβ and IL18 were expressed in both stimulated and unstimulated bone marrow-derived macrophages (Fig. 2), and the expression of both TNFα and TGFβ increased after stimulation. In contrast, IL12 p35 expression was found only after stimulation with IFNγ and LPS (Fig. 2).

Fig. 2
Levels of IL12p53, IL18, TNFα and TGFβ mRNA in cotton rat macrophages. Expression levels of IL12p35, IL18, TNFα and TGFβ mRNA were determined in untreated (white bars) and stimulated macrophages (gray bars) by SYBR green ...

3.4. Phagocytosis of L. monocytogenes by cotton rat macrophages

A hallmark of macrophage function is its antimicrobial activity through phagocytosis. Phagocytosis is defined as the binding, up-take and killing of bacteria in lysosomal compartments. In order to observe these different steps, we established both a confocal microscopy assay to visualize intracellular compartments of infected macrophages and a bacterial killing assay. For infection of macrophages a L. monocytogenes mutant was used in which the gene for superoxide dismutase (sod A) was replaced by green fluorescent protein (GFP) [32]. This mutant constitutively expresses GFP, is fully functionally in tissue culture and easily visible by UV-light microscopy (data not shown). In order to visualize different cellular compartments of macrophages and to follow the route of infection by the Listeria mutant, dyes staining DNA in the nucleus (Hoechst stain 33258), the F actin skeleton (Alexa Fluor 633 phalloidin) and the phagolysosome (LysoTracker Red) were used. Infected cells were analyzed at different time points by confocal microscopy. As previously published for mouse macrophages, infection with L. monocytogenes lead to binding and up-take of bacteria. Listeria infection stimulated the generation of phagolysosomes (containing bacteria) and disrupted the regularly structured cytoskeleton (actin F filaments, data not shown). In order to demonstrate bactericidal activity, macrophages were incubated with L. monocytogenes and lysates were prepared directly or after 2-h incubation. Cotton rat macrophages reduced the number of intracellular L. monocytogenes by >0.2 log 10 (difference between T0 and T2 hours) which is considered to be bactericidal activity [35] although the difference did not reach statistical significance. As a facultative intracellular bacterium, L. monocytogenes is relatively resistant against lysis by macrophages. Relative to L. monocytogenes, activated cotton rat bone marrow-derived macrophages lysed E. coli (Fig. 5) more efficiently and E. coli was used for further phagocytosis assays.

Fig. 5
Inhibition of bacterial killing assay by inhibition of nitric oxide. Bone marrow-derived macrophages (5 × 105/well) were plated in 24-well plates and primed for 48 h with 0.5 µg/ml recombinant cotton rat IFNγ. Wells were incubated ...

3.5. ROI and NO generation in cotton rat macrophages

Killing of bacteria after phagocytosis by macrophages is typically achieved by a combination of methods including vesicle acidification, enzymatic digestion and reactive oxygen (ROI) and nitrogen intermediates. As a marker of antibacterial activity, the generation of superoxide, hydrogen peroxide and nitric oxide by cotton rat macrophages were measured. To stimulate the production of these molecules, cotton rat macrophages were primed with IFNγ (2, 4, 6, 8 or 10 U/mL) or supernatant from Concanavalin A stimulated spleen cells (containing IFNγ), and triggered with 100 ng/mL LPS and Listeria monocytogenes (MOI = 10), PMA 100 ng/mL or TNFα 10 pg/mL. After the stimulation, there was an increase in the generation of superoxide and hydrogen peroxide by macrophages (Fig. 3A). However, no nitric oxide production by cotton rat macrophages was observed (Fig. 3B). In contrast, mouse bone marrow-derived macrophages secreted high amounts of nitric oxide (Fig. 3B). In order to exclude the possibility that the lack of NO secretion was specific for bone marrow-derived macrophages, peritoneal macrophages were obtained and tested with various stimuli. However, no secretion of NO was found (data not shown). The Griess reaction used to measure nitrite (a stable product of NO) has a limit of detection in the low micromolar range. Furthermore, we tested the production of NO in supernatants of cotton rat macrophages by electron paramagnetic resonance (EPR) spin trapping. Even with this sensitive technique, no nitric oxide production was observed (data not shown). To test for the presence of intracellular nitric oxide, cells were preloaded with the NO-specific intracellular fluorophore, diaminofluorescein-2 diacetate (DAF-2A), and results indicated the production of intracellular NO (Fig. 4). In addition, mRNA for inducible nitric oxide synthase 2 (NOS2) was detected by PCR from these macrophages (data not shown). These data indicate that cotton rat macrophages are very similar to human macrophages in that they express very little NO (in contrast to mouse macrophages). However, even low amounts of NO produced by human macrophages may have the antibacterial activity [5]. In order to determine whether this was also true for cotton rat macrophages, an inhibitor of NO production was used. Macrophages treated with the NOS2 inhibitor 1400 W, demonstrated increased growth of bacteria as compared to bacterial growth in mock-treated macrophages (Fig. 5).

Fig. 3
Secretion of superoxide, hydrogen peroxide and nitric oxide by cotton rat macrophages. Addition of zymosan to IFNγ primed cotton rat bone marrow-derived macrophages (106 per well) leads to secretion of extracellular superoxide (O2) and ...
Fig. 4
Fluorescent microscopy of diaminofluorescein diacetate (DAF2A) stained cotton rat bone marrow-derived macrophages. Cotton rat macrophages were treated with the fluorophore DAF2A which can be detected by UV light (bottom) after reaction with nitric oxide ...

4. Discussion

In the present study, we have described the culture of bone marrow-derived macrophages from cotton rats and characterized them phenotypically and functionally. Culture conditions used for the generation of mouse bone marrow-derived macrophages proved to be satisfactory for cotton rat bone marrow-derived macrophages, too. Cotton rat macrophages display typical characteristics of macrophages including plastic adherence, the presence of granules containing non-specific esterase, expression of MHC I, MHC II, CD14, and production of TNFα, TGFβ, IL12 and IL18 mRNA. One difference to other rodent macrophages was the expression of MHC II. In mouse and rat BMDM expression levels of MHC II molecules are high (60% [36] and 30% [37], respectively) whereas in cotton rat macrophages expression is low although it can be stimulated with IFN γ. Cotton rat macrophages also do not express CD4, similar to the mouse, but in contrast to rat and human macrophages [38]. In functional assays, cotton rat macrophages ingest bacteria into lysosomes and are able to kill them. In contrast to macrophages from a variety of rodents like mouse [39], gerbil, mastomys [40] and rats [2], cotton rat macrophages express low amounts of nitric oxide. Previous studies have shown that the induction of interferon regulatory factor 1 (IRF1) by IFNγ up-regulates the NOS2 promoter and this stimulation is counteracted by TGFβ [41]. Constitutive TGFβ mRNA expression is found in cotton rat macrophages. However, further studies have to elucidate whether this is the mechanical reason for the low level of NO expression.

The apparent difference between mouse and cotton rat is of particular interest for the study of infectious diseases. Mice have been used to study a variety of infectious diseases, as they are genetically and immunologically well-defined animal models. However, the increasing body of evidence demonstrate a large difference in the immune system of mouse and humans [42]. Of interest in the current study is to investigate the differences in NO generation. The production of NO by mouse macrophages in culture has been demonstrated and correlated with its antibacterial effects [39]. Further, the role of NO in the antibacterial actions has been confirmed with use of NO inhibitors and the deletion of the NOS2 gene [39]. In contrast, human macrophages secrete very little NO [43]. A large number of studies have demonstrated that the detection of NO production by human macrophages (peritoneal, alveolar or bone marrow-derived) is very difficult and often relies on the detection of NOS2 mRNA by PCR or Northern blotting or by immunohistochemistry in lung tissue [3]. These data have been interpreted as NO having more of a signal transduction function in human macrophages whereas reactive oxygen intermediates (like superoxide and hydrogen peroxide) are thought to be the effector molecules for antibacterial function. This seems to be true for the killing of a variety of bacteria, protozoa and helminthes, if chemokines, cytokines and bacterial products are used to activate macrophages [3]. However, activation of human macrophages with surfactant protein A resulted in NO production and killing of Klebsiella by human macrophages [5]. Interestingly enough, NO secretion by human macrophages is enhanced when alveolar macrophages are obtained from patients with lung injury, chronic lung inflammation [3] or patients with tuberculosis [44,45]. In the latter case, killing of mycobacteria in vitro by these macrophages was inhibited by NO inhibitors, thus indicating an antimicrobial role for NO, possibly also in humans during mycobacterial infection [46]. Currently, the mouse is an often-used animal model for the study of tuberculosis, and whether the differences in the antibacterial properties of human and mouse macrophages are relevant to study outcomes in the mouse has not been determined. Recently, it has been shown that cotton rats are an excellent model for infection studies with Mycobacterium tuberculosis [24]. As cotton rat macrophages display a NO secretion pattern similar to humans it would be of interest to study the role of NO in M. tuberculosis immunity in these animals.


1. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Ann Rev Immunol. 2002;20:825–852. [PubMed]
2. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Ann Rev Immunol. 1997;15:323–350. [PubMed]
3. Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med. 1998;4(9):557–591. [PMC free article] [PubMed]
4. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SM, Nascimento ET, et al. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol. 2001;167:893–901. [PubMed]
5. Hickman-Davis JM, O’Reilly P, Davis IC, Peti-Peterdi J, Davis G, Young KR, et al. Killing of Klebsiella pneumoniae by human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2002;282:L944–L954. [PubMed]
6. Niewiesk S, Prince GA. Diversifying animal models: the use of hispid cotton rats (Sigmodon hispidus) in infectious diseases. Lab Anim. 2002;36:357–372. [PubMed]
7. Wyde PR, Ambrosi MW, Voss TG, Meyer HL, Gilbert BF. Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proc Soc Exp Biol Med. 1992;201:80–87. [PubMed]
8. Wyde PR, Moore-Poveda DK, Daley NJ, Oshitani H. Replication of clinical measles virus strains in hispid cotton rats. Proc Soc Exp Biol Med. 1999;221:53–62. [PubMed]
9. Dreizin RS, Vyshnevetskaia LO, Bagdamian EE, Iankevich OD, Tarasova LB. Experimental RS virus infection of cotton rats. A viral and immunofluorescent study. Vop Virusol. 1971;16:670–676. (article in Russian) [PubMed]
10. Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncitial virus (RSV) or purified F glacoprotein and challenged with RSV 3–6 months after immunization. Vaccine. 1990;8:497–502. [PubMed]
11. Wyde PR, Chetty SN, Jewell AM, Schoonover SL, Piedra PA. Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines. Antivir Res. 2005;2005:57–66. [PubMed]
12. Williams JV, Tollefson SJ, Johnson JE, Crowe JE., Jr The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol. 2005;79(17):10944–10951. [PMC free article] [PubMed]
13. Hamelin ME, Yim K, Kuhn KH, Cragin RP, Boukhvalova M, Blanco JC, et al. Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol. 2005;79(14):8894–8903. [PMC free article] [PubMed]
14. Murphy TF, Dubovi EJ, Clyde WA. The common cotton rat as an experimental model of human parainfluenzy virus type 3 disease. Exp Lung Res. 1981;2:97–109. [PubMed]
15. Brydak L. Studies on adaptation of influenza virus replicated at low temperature. IV. Sensitivity of neuraminidase and hemagglutinin to some proteolytic enzymes, detergents and chemical agents. Acta Microbiol Pol. 1990;39:137–147. [PubMed]
16. Ottolini M, Blanco J, Porter D, Peterson L, Curtis S, Prince G. Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediatr Pulmonol. 2003;36(4):290–294. [PubMed]
17. Rytik PG, Kucherov II, Muller WE, Podoĺskaia IA, Kruzo M, Duboiskaia GP, et al. The use of the polymerase chain reaction in modelling HIV infection in animals (Russian) Zh Mikrobiol Epidemiol Immunobiol. 1995;8:86–89. [PubMed]
18. Langley RJ, Prince GA, Ginsberg HS. HIV type-1 infection of the cotton rat (Sigmodon fulviventer and S. hispidus) Proc Natl Acad Sci. 1998;95:14355–14360. [PubMed]
19. Lewandowski G, Zimmerman MN, Denk LL, Porter DD, Prince GA. Herpes simplex type 1 infects and establishes latency in the brain and trigeminal ganglia during primary infection of the lip in cotton rats and mice. Arch Virol. 2002;147:167–179. [PubMed]
20. Yim KC, Carroll CJ, Tuyama A, Cheshenko N, Carlucci MJ, Porter DD, et al. The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies. J Virol. 2005;79:14632–14639. [PMC free article] [PubMed]
21. Pacini DL, Dubovi EJ, Clyde WA. A new animal model for human respiratory tract disease due to adenovirus. J Infect Dis. 1984;150:92–97. [PubMed]
22. Mähler M, Heidtmann W, Hedrich HJ, Beil W, Gruber A, Niewiesk S, et al. Helicobacter pylori infection induces chronic active gastritis in cotton rats. Gastroenterology. 2002;122:A532–A533.
23. Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T, Kalbacher H, Gross M, et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med. 2004;10:243–245. [PubMed]
24. Elwood RL, Wilson S, Blanco JC, Yim K, Pletneva L, Nikonenko B, et al. The American cotton rat: a novel model for pulmonary tuberculosis. Tuberculosis. 2007;87:145–154. [PubMed]
25. Burgdorfer W, Gage KL. Susceptibility of the hispid cotton rat (Sigmodon hispidus) to the Lyme disease spirochete (Borrelia burgdorferi) Am J Trop Med Hyg. 1987;37:624–628. [PubMed]
26. Oliver JH, Chandler FW, James AM, Sanders FH, Hutcheson HJ, Huey LO, et al. Natural occurence and characterization of the Lyme spirochete, Borrelia burgdorferi, in cotton rats (Sigmodon hispidus) from Georgia and Florida. J Parasitol. 1995;81:30–36. [PubMed]
27. Lowery GH. The mammals of Lousiana and its adjacent waters. Baton Rouge: Louisiana State University Press; 1981.
28. Blanco JC, Pletneva L, Boukhvalova M, Richardson JY, Harris KA, Prince G. The cotton rat: an underutilized animal model for human infectious diseases can now be exploited using specific reagents to cytokines, chemokines, and interferons. J Interferon Cytokine Res. 2004;24:21–28. [PubMed]
29. Shields MJ, Ribaudo RK. Mapping of the monoclonal antibody W6/32: sensitivity to the amino terminus of beta2-microglobulin. Tissue Antigens. 1998;51:567–570. [PubMed]
30. Hämmerling GJ, Hämmerling U, Lemke H. Isolation of twelve monoclonal antibodies against Ia and H-2 antigen. Serological characterization and reactivity with B- and T-lymphocytes. Immunogenetics. 1979:433–445. 1979.
31. Pueschel K, Tietz A, Carsillo M, Steward M, Niewiesk S. Measles virus-specific CD4 T-cell activity does not correlate with protection against lung infection or viral clearance. J Virol. 2007;81(16):8571–8578. [PMC free article] [PubMed]
32. Bubert A, Sokolovic Z, Chun SK, Papatheodorou L, Simm A, Goebel W. Differential expression of Listeria monocytogenes virulence genes in mammalian host cells. Mol Gen Genet. 1999;261:323–336. [PubMed]
33. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem. 1996;271(46):29223–29230. [PubMed]
34. Pandian RP, Kutala VK, Liaugminas A, Parinandi NL, Kuppusamy P. Lipopoly-saccharide-induced alterations in oxygen consumption and radical generation in endothelial cells. Mol Cell Biochem. 2005;278(1–2):119–127. [PubMed]
35. Campbell PA, Canono BP, Drevets DA. Measurement of bacterial ingestion and killing by macrophages. In: Coico R, editor. Current protocols in immunology. John Wiley and Sons; 2001. pp. 14.6.1–14.6.13.
36. Schook LB, Bingham EL, Gutmann DH, Niederhuber JE. Characterization and expression of H-21 region gene products on bone marrow-derived macrophages. Eur J Immunol. 1982;12:991–997. [PubMed]
37. Gessl A, Krugluger W, Langer K, Baumgartner I, Spittler A, Grabner G, et al. Expression of MHC class II antigens on rat bone marrow cells and macrophages, and their modulation during culture with murine GM-CSF or M-CSF. Immunobiology. 1995;192:185–197. [PubMed]
38. Crocker PR, Jefferies WA, Clark SJ, Chung LP, Gordon S. Species heterogeneity in macrophage expression of the CD4 antigen. J Exp Med. 1987;166:613–618. [PMC free article] [PubMed]
39. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest. 1997;100(10):2417–2423. [PMC free article] [PubMed]
40. Gupta R, Bajpai P, Tripathi LM, Srivastava VM, Jain SK, Misra-Bhattacharya S. Macrophages in the development of protective immunity against experimental Brugia malayi infection. Parasitology. 2004;129(Pt 3):311–323. [PubMed]
41. McCartney-Francis NL, Wahl SM. lation of IFN-gamma signaling pathways in the absence of TGF-beta 1. J Immunol. 2002;169:5941–5947. [PubMed]
42. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172:2731–2738. [PubMed]
43. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis. 1993;167:1358–1563. [PubMed]
44. Schon T, Elmberger G, Negesse Y, Pando RH, Sundqvist T, Britton S. Local production of nitric oxide in patients with tuberculosis. Int J Tuberc Lung Dis. 2004;8(9):1134–1137. [PubMed]
45. Sable SB, Goyal D, Verma I, Behera D, Khuller GK. Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins. Eur Respir J. 2007;29:337–346. [PubMed]
46. Bose M, Farnia P, Sharma S, Chattopadhya D, Saha K. Nitric oxide dependent killing of mycobacterium tuberculosis by human mononuclear phagocytes from patients with active tuberculosis. Int J Immunopathol Pharmacol. 1999;12(2):69–79. [PubMed]